Answers are grounded in this paper and cite their sources.
We report the case of a 13-year-old boy with SHORT syndrome, including lipoatrophy and insulin resistance, who developed diabetes mellitus while receiving growth hormone therapy. The diabetes persisted after cessation of exogenous growth hormone but oral hypoglycaemic therapy was successful and could be discontinued eight months later.
No takes yet. Share an insight, caveat, or question.
Verge et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: